NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - GeoVax Labs, Inc. - 2.02 / 9.01

Filed: 2026-04-15 AccNo: 0001437749-26-012435 Size: 269 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/15 21:20 UTC
首次发现04/16 02:15 UTC
热度95.6
重要度76
情绪+0.04

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 737 字符

Form 8-K - Current report: SEC Accession No. 0001437749-26-012435

Filing Date: 2026-04-15

Accepted: 2026-04-15 17:20:36

Documents: 14

Period of Report: 2026-04-15

Items: Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

GeoVax Labs, Inc. (Filer) CIK : 0000832489 (see all company filings) EIN. : 870455038 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 26864951 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | FORM 8-K | govx20260415_8k.htm iXBRL | 8-K

2 | EXHIBIT 99.1 | ex_945907.htm | EX-99.1

7 | logosm.jpg | GRAPHIC | 12780

3 | XBRL TAXONOMY EXTENSION SCHEMA | govx-20260415.xsd | EX-101.SCH